PRECLINICAL ALZHEIMER'S DISEASE
Clinical trials for PRECLINICAL ALZHEIMER'S DISEASE explained in plain language.
Never miss a new study
Get alerted when new PRECLINICAL ALZHEIMER'S DISEASE trials appear
Sign up with your email to follow new studies for PRECLINICAL ALZHEIMER'S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Race to stop Alzheimer's before it starts: new vaccine enters major trial
Disease control OngoingThis study is testing whether an experimental vaccine can slow or prevent cognitive decline in people who have early Alzheimer's-related brain changes but no memory symptoms yet. About 500 participants will receive either the vaccine or a placebo and be followed for about 4 years…
Matched conditions: PRECLINICAL ALZHEIMER'S DISEASE
Phase: PHASE2 • Sponsor: Janssen Pharmaceutica N.V., Belgium • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Race to stop Alzheimer's before it starts: major drug trial targets silent brain changes
Prevention OngoingThis large study is testing whether the drug lecanemab can prevent or delay Alzheimer's disease in people who have early signs of the disease in their brains but do not yet have memory problems or other symptoms. It involves 1,400 participants aged 55-80 who have intermediate or …
Matched conditions: PRECLINICAL ALZHEIMER'S DISEASE
Phase: PHASE3 • Sponsor: Eisai Inc. • Aim: Prevention
Last updated Mar 09, 2026 14:23 UTC